Search Ontology:
ChEBI
cobimetinib
- Term ID
- CHEBI:90851
- Synonyms
-
- [3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl}methanone
- cobimetinib
- GDC 0973
- GDC-0973
- GDC0973
- RG 7420
- RG7420
- Xl 518
- Xl-518
- XL518
- Definition
- A member of the class of N-acylazetidines obtained by selective formal condensation of the carboxy group of 3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoic acid with the secondary amino group from the azetidine ring of 3-[(2S)-piperidin-2-yl]azetidin-3-ol. An inhibitor of mitogen-activated protein kinase that is used (as its fumarate salt) in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma.
- References
-
- cas:934660-93-2
- drugbank:DB05239
- drugcentral:5046
- kegg.drug:D10405
- pdb-ccd:EUI
- pubmed:24589925
- pubmed:25037139
- pubmed:25142409
- pubmed:25243894
- pubmed:25265494
- pubmed:25444546
- pubmed:25813936
- pubmed:26365290
- pubmed:26384788
- pubmed:26451002
- pubmed:26452567
- reaxys:12883594
- wikipedia.en:Cobimetinib
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from cobimetinib
Phenotype where environments contain cobimetinib
Phenotype modified by environments containing cobimetinib
Phenotype affecting cobimetinib
Human Disease Model